Novel Troponin Fragmentation Assay to Discriminate Between Troponin Elevations in Acute Myocardial Infarction and End-Stage Renal Disease

Circulation. 2022 Nov;146(18):1408-1410. doi: 10.1161/CIRCULATIONAHA.122.060845. Epub 2022 Oct 31.

Authors

K E Juhani Airaksinen^#¹, Rami Aalto^#², Tapio Hellman³, Tuija Vasankari¹, Akseli Lahtinen², Saara Wittfooth²

Affiliations

¹ Heart Center (K.E.J.A., T.V.), Turku University Hospital and University of Turku, Finland.
² Biotechnology Unit, Department of Life Technologies, University of Turku, Finland (R.A., A.L., S.W.).
³ Kidney Center (T.H.), Turku University Hospital and University of Turku, Finland.

^# Contributed equally.

PMID: 36315607
DOI: 10.1161/CIRCULATIONAHA.122.060845

No abstract available

Keywords: ST elevation myocardial infarction; kidney failure, chronic; myocardial infarction; non-ST elevated myocardial infarction; troponin T.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Biomarkers
Humans
Kidney Failure, Chronic* / diagnosis
Myocardial Infarction* / diagnosis
Non-ST Elevated Myocardial Infarction*
Troponin
Troponin T

Substances

Troponin
Troponin T
Biomarkers

Associated data

ClinicalTrials.gov/NCT04465591